Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Nuvista Energy Ltd (NUVSF)

Nuvista Energy Ltd (NUVSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Top 3 Reasons Oil Prices Will Remain Elevated BayStreet.ca - Wed Mar 16, 2022

Over the last few weeks, crude oil prices gushed from a low of about $65 to $130.50. All thanks to Russia’s invasion of Ukraine. While oil has since corrected to $97, the pullback may only be temporary....

NVA.TO : 11.38 (+1.79%)
NUVSF : 8.1100 (+0.37%)
OAS : 109.30 (-10.15%)
XOM : 114.95 (-1.57%)
CVX : 153.07 (+2.86%)
IPO.TO : 1.89 (unch)
IPOOF : 1.3600 (-1.45%)
With the Potential for $100 Oil, Pay Close Attention to These Stocks BayStreet.ca - Wed Feb 2, 2022

Oil prices could hit $90 a barrel again soon. By summer, it could be closer to $100, possibly even $117, according to Bank of America. That’s all thanks to tighter oil supply, stronger demand, geopolitical...

BAC : 41.76 (-0.14%)
MS : 116.85 (+0.52%)
NVA.TO : 11.38 (+1.79%)
NUVSF : 8.1100 (+0.37%)
OAS : 109.30 (-10.15%)
XOM : 114.95 (-1.57%)
CVX : 153.07 (+2.86%)
IPO.TO : 1.89 (unch)
IPOOF : 1.3600 (-1.45%)

Barchart Exclusives

Thanks to Wall Street, Novo Nordisk Stock is Now a Buy Barchart - Sat Nov 2, 10:15AM CDT
Novo Nordisk has lost about a quarter of its value since the end of June. Meanwhile, indications are that its diabetes and weight-loss drugs may be useful in fighting cardiovascular disease, arthritis, opioid and alcohol addiction, and Alzheimer's. Novo remains a leader in the sector, and is trading at a valuation a third cheaper than competitor, Eli Lilly. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot